Skip to main navigation Skip to search Skip to main content

Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus

  • Dolly Aguilera
  • , Robert Flamini
  • , Claire Mazewski
  • , Matthew Schniederjan
  • , Laura Hayes
  • , William Boydston
  • , Robert C. Castellino
  • , Tobey J. MacDonald
  • Emory University
  • Department of Neurology
  • Children's Healthcare of Atlanta

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Background: Brain subependymal giant cell astrocytomas (SEGAs) in patients with tuberous sclerosis have been reported to respond to everolimus.

Methods: A 15-year-old male patient with intractable seizures and multiple SEGAs of the brain developed leptomeningeal enhancement and multiple metastatic, histologically confirmed SEGAs of the spinal cord. He received daily everolimus at a dose of 3 mg/m2 for 6 weeks, which was then increased to 6 mg/m2.

Results: Magnetic resonance image of the brain and spine showed significant reduction in the size of SEGAs after 6 weeks of treatment. The patient has remained free of progression for 24 months. Additional benefits included: excellent seizure control, decrease in the size of cardiac rhabdomyomas, and improved quality of life.

Conclusions: We describe a rare case of metastatic SEGA, which was successfully treated with everolimus.

Original languageEnglish
Pages (from-to)e448-e451
JournalJournal of Pediatric Hematology/Oncology
Volume36
Issue number7
DOIs
StatePublished - 8 Oct 2014

Keywords

  • Everolimus
  • SEGA
  • Spinal cord
  • Tuberous sclerosis

Fingerprint

Dive into the research topics of 'Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus'. Together they form a unique fingerprint.

Cite this